MultivisionDx (private company)
See something wrong or missing? Let us know
Offices:Helsinki
Business model:B2BSAAS
MultivisionDx is a software startup in Finland developing an AI spatial biology platform, which analyzes tumor biopsies to create patient-specific “cancer fingerprints” - predicting treatment responses far more accurately than standard methods.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 1.16M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to MultivisionDx
| Name | Criteria | |
|---|---|---|
![]() |
Molecule.one
80%
|
|
![]() |
Scienta Lab
80%
|
|
![]() |
Generare
80%
|
|
![]() |
Cranebio
80%
|
|
![]() |
AMPLY Discovery
80%
|
|
![]() |
Monocl
75%
|
|
![]() |
Valink Therapeutics
75%
|
|
![]() |
Causaly
75%
|
|
![]() |
Clustermarket
75%
|
|
![]() |
Overwatch Research
75%
|
|





Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain